EVRY, France--(BUSINESS WIRE)-- <\/p>\n
Global Bioenergies (ALGBE.PA), an industrial biology company developing sustainable routes to light olefins, has been nominated as one of the five most innovative European biotech SMEs by EuropaBio, representing more than 1800 European companies. <\/p>\n
EuropaBio, the principal organization to represent more than 1800 of Europes biotechnology companies, has communicated the choice of its expert panel for the Most Innovative EU Biotech SME Award 2012 in the press release which can be found under http:\/\/www.europabio.org\/sme\/press\/who-are-europes-5-most-innovative-biotech-smes<\/a>. <\/p>\n The award ceremony will be held on September 19th in the European Parliament by Commission Vice President Antonio Tajani, Commissioner for Industry & Entrepreneurship. <\/p>\n Marc Delcourt, co-founder and CEO of Global Bioenergies, comments: We are very honored by the choice of the expert panel of this prestigious biotechnology award, in particular because it was open to all European biotechnology companies acting in fields as diverse as pharmaceuticals, diagnostics, plant science, environment and industrial biology. We would like to thank EuropaBio for their recognition of our unique synthetic biology-based approach to convert renewable resources into light olefins, the core molecules of the petrochemical industry, and more generally for their support to the emerging industrial biology community. <\/p>\n About GLOBAL BIOENERGIES <\/p>\n Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the yield of its process and prepares the phase dedicated to pilot testing. The company is also looking to replicate this success with other members of the gaseous olefins family (propylene, ethylene, linear butylenes, butadiene), key molecules at the heart of petrochemical industry. Global Bioenergies is listed on NYSE Alternext Paris (FR0011052257 ALGBE). <\/p>\n Should you like to be kept informed, subscribe to our news feed on http:\/\/www.global-bioenergies.com<\/a> <\/p>\n<\/p>\n See the original post here: EVRY, France--(BUSINESS WIRE)-- Global Bioenergies (ALGBE.PA), an industrial biology company developing sustainable routes to light olefins, has been nominated as one of the five most innovative European biotech SMEs by EuropaBio, representing more than 1800 European companies. EuropaBio, the principal organization to represent more than 1800 of Europes biotechnology companies, has communicated the choice of its expert panel for the Most Innovative EU Biotech SME Award 2012 in the press release which can be found under http:\/\/www.europabio.org\/sme\/press\/who-are-europes-5-most-innovative-biotech-smes<\/a>. The award ceremony will be held on September 19th in the European Parliament by Commission Vice President Antonio Tajani, Commissioner for Industry & Entrepreneurship. Continue reading
\nGLOBAL BIOENERGIES\u00a0nominated as one of the five most innovative European biotech SMEs by EuropaBio<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"